Early Access — free while we kick the tires
EdgarHawk

YOUNG RODNEY A

Director

Director
4 filings analyzed · 1 company · Latest 2026-03-17

Companies

Company Buys Sells Direction
CBIZ, Inc. CBZ 4 0 Net buying

Activity

March 2026
2026-03-17 CBIZ, Inc. CBZ
medium
Buy
1,000 shares
$26,055
Significance 4/10

Director Rodney Young buys 1,000 CBZ shares at $26.06; stock down 49.7% in 90 days, prior buys at ticker also underwater.

Rodney Young, a director of CBIZ, Inc., purchased 1,000 shares at $26.06 on 2026-03-13, increasing his holdings from 8,310 to 9,310 shares. The stock has declined significantly since the transaction: it now trades at $26.49 (−66.7% from its 52-week high of $79.64) and has fallen 49.7% over the past 90 days. Critically, Young's prior three buys at this same ticker—conducted on 2025-08-08, 2025-03-04, and 2024-12-09—all showed negative 90-day returns (−14.2%, −6.0%, and −6.3% respectively), with zero of these three prior buys achieving positive 90-day returns. This pattern suggests the director's timing in accumulating CBZ shares has been consistently poor, with his latest purchase also now underwater. Despite strong fundamentals (revenue of $693,818,000.00, net income of $30,146,000.00, annual revenue growth of +52.1%, and a low P/E of 7.42), the repeated accumulation into a declining stock warrants investor attention to the disconnect between company health and recent stock-price trajectory.

August 2025
2025-08-12 CBIZ, Inc. CBZ
medium
Buy
2,000 shares
$124,860
Significance 4/10

Director Rodney A Young bought 2,000 shares of CBZ at $62.43; stock down 29.0% from 52-week high.

Director Rodney A Young purchased 2,000 shares at $62.43 on 2025-08-08, increasing his holdings by 31.7% to 8,310 shares. The purchase occurs with CBZ trading 29.0% below its 52-week high of $88.65 and 12.8% lower over the past 30 days. Notably, his prior two purchases at CBZ (on 2025-03-04 and 2024-12-09) both resulted in negative 90-day returns of -3.0% and -6.0% respectively, indicating a pattern of unfavorable timing on open-market acquisitions at this ticker. While CBZ fundamentals show solid growth with +14.0% annual revenue expansion and $683.5M in quarterly revenue, the persistent decline in recent price action combined with his prior transaction outcomes at this specific ticker warrant investor attention to whether current positioning reflects conviction or follows a pattern of challenging entry points.

March 2025
2025-03-06 CBIZ, Inc. CBZ
medium
Buy
1,000 shares
$76,180
Significance 5/10

Director Rodney Young buys 1,000 CBZ shares at $76.18; stock down 19.2% from 52-week high, now at $71.66

Director Rodney Young purchased 1,000 shares of CBIZ, Inc. at $76.18 on 2025-03-04, increasing his holdings by 33.9% from 2,949 to 3,949 shares. The transaction occurs amid significant recent price weakness: CBZ has declined 16.4% over the past 30 days and 19.2% from its 52-week high of $88.65, now trading at $71.66. While the company shows solid fundamentals with $438.9M in latest quarterly revenue, 14.0% annual growth, and $35.1M in net income, the elevated P/E of 98.16 suggests the stock may be pricing in substantial future growth expectations. Young's only prior CBZ trade was a buy on 2024-12-09 with a measurable 30-day return of +6.8%, though the 90-day outcome is not yet determinable. The current purchase adds to his position at materially lower prices than his previous entry point.

December 2024
2024-12-11 CBIZ, Inc. CBZ
medium
Buy
1,000 shares
$77,556
Significance 6/10

Director Rodney Young buys 1,000 CBZ shares at $77.56, increasing holdings 51.3% to 2,949 shares

Rodney Young, a director of CBIZ Inc., purchased 1,000 shares at $77.56 on 2024-12-09 for $77,556.00, increasing his shareholdings from 1,949 to 2,949 shares—a 51.3% increase in personal holdings. The transaction occurred at a price approximately $0.34 below the current market price of $77.90, and within the 52-week trading range of $57.84–$86.02. The company's recent fundamentals show revenue of $438,884,000.00 with net income of $35,084,000.00 in the latest quarter, alongside annual revenue growth of 12.7%, though the stock trades at a relatively elevated P/E ratio of 32.87. This substantial increase in director holdings relative to his prior position warrants monitoring of insider disposition patterns going forward.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access